Aging is recognized as a major risk factor for neurodegenerative diseases, among which Parkinson’s disease (PD) is characterized by motor impairments and the progressive loss of dopaminergic neurons in the substantia nigra. While earlier research ha...
Aging is recognized as a major risk factor for neurodegenerative diseases, among which Parkinson’s disease (PD) is characterized by motor impairments and the progressive loss of dopaminergic neurons in the substantia nigra. While earlier research has primarily focused on alterations within the nigrostriatal pathway, growing evidence suggests that structural and functional abnormalities of the cerebellum also contribute to the clinical manifestations of PD. In particular, the vulnerability and degeneration of Purkinje cells have emerged as critical pathological features associated with PD-related motor dysfunction.
Fetuin-A, a multifunctional glycoprotein predominantly synthesized in the liver but also expressed in the central nervous system, has been implicated as a regulatory factor reflecting neuronal injury and prognosis. Previous findings demonstrated that reduced expression of Fetuin-A in cerebellar Purkinje cells is closely associated with morphological abnormalities and increased cellular vulnerability in PD models.
Resveratrol (RES), Saffron-derived antioxidant (SDA), and Passiflora incarnata L.(PI) are natural extracts with potent antioxidant activities, known to enhance neuronal survival by scavenging reactive oxygen species (ROS), preserving mitochondrial function, and attenuating inflammatory signaling. Considering that oxidative stress contributes to both the reduction of Fetuin-A and increased susceptibility of Purkinje cells in PD, these extracts may exert protective effects through the modulation of Fetuin-A expression.
In the present study, we evaluated the effects of these three natural extracts on Fetuin-A expression and Purkinje cell preservation in an MPTP-induced PD mouse model. Additionally, primary cerebellar neurons derived from E18 embryos were used to assess the antioxidant and neuroprotective effects of each extract under MPP⁺-induced PD-like conditions in vitro.
Pretreatment with natural extracts significantly attenuated the MPTP-induced downregulation of Fetuin-A in cerebellar Purkinje cells and reduced the number of TUNEL-positive and cleaved caspase-3 (CC3)-positive cells, indicating suppression of apoptotic activation. The proportion of Fluoro-Jade C–positive Purkinje cells was also markedly reduced, demonstrating a strong inhibitory effect on Purkinje cell degeneration. These protective effects were accompanied by partial preservation of motor function. Consistent results were observed in vitro, where extract pretreatment preserved Fetuin-A expression and reduced ROS accumulation in MPP⁺-treated neurons.
Collectively, these findings suggest that natural extracts with antioxidant properties mitigate the MPTP-induced decrease in Fetuin-A expression and contribute to the preservation of Purkinje cell integrity. This study provides evidence supporting the potential of these natural compounds as preventive therapeutic strategies targeting cerebellar pathology in Parkinson’s disease.